Hillary Clinton said Wednesday that the price of EpiPen is “outrageous” and called on manufacturer Mylan to lower the price of the life-saving device used to treat serious allergic reactions.
“That’s outrageous—and it’s just the latest troubling example of a company taking advantage of its consumers,” Clinton said in a statement. “It’s wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them.”
The Democratic presidential nominee was responding to price increases of the EpiPen, a preloaded injection of epinephrine or adrenaline that can treat anaphylactic shock. The device has more than quadrupled in the past decade, from $100 in 2008 to its current price of $600.
Clinton joins a bipartisan group of legislators, including Republican Iowa Sen. Chuck Grassley and Democratic Minnesota Sen. Amy Klobuchar, who have called for an explanation or an investigation into the price increase. Mylan CEO Heather Bresch is the daughter of Democratic Sen. Joe Manchin of West Virginia.
More Must-Reads from TIME
- How Donald Trump Won
- The Best Inventions of 2024
- Why Sleep Is the Key to Living Longer
- Robert Zemeckis Just Wants to Move You
- How to Break 8 Toxic Communication Habits
- Nicola Coughlan Bet on Herself—And Won
- Why Vinegar Is So Good for You
- Meet TIME's Newest Class of Next Generation Leaders
Contact us at letters@time.com